跳至主要内容
临床试验/CTRI/2025/12/098241
CTRI/2025/12/098241尚未招募不适用

Association of Adipose-Muscle Phenotypes with Clinical and Metabolic Parameters in Adult Patients with Metabolic-Associated Steatotic Liver Disease (MASLD)

ICMR1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2025年12月15日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
ICMR
入组人数
400
试验地点
1
主要终点
identification of significant associations between Adipose-Muscle Phenotypes characterized by variations in visceral fat and lean mass and clinical and metabolic parameters in MASLD patients

研究概览

简要总结

Rationale: MASLD is a growing global health concern, strongly linked to obesity, insulin resistance, and systemic inflammation. However, obesity is a heterogeneous condition, and patients with similar BMI may exhibit varying fat distribution and muscle mass, influencing MASLD progression. Current diagnostic criteria overlook these variations, leading to misclassification of disease risk and suboptimal management strategies. Understanding these differences is crucial for improving disease assessment and therapeutic interventions.

Novelty: This study investigates distinct Adipose-Muscle Phenotypes in MASLD patients, an under-explored area. Unlike traditional BMI-based classifications, it emphasizes visceral fat, lean mass, and their interplay in disease progression. It integrates muscle strength, sleep quality, eating behavior, and physical activity to provide a comprehensive metabolic health assessment. This approach could redefine risk stratification and therapeutic strategies for MASLD.

Objectives: The objective is to examine the association between Adipose-Muscle Phenotypes, categorized based on visceral fat and lean mass levels, clinical and metabolic parameters in MASLD patients. The study also aims to compare muscle strength, quality of life, sleep quality, eating behavior, physical activity across these phenotypes.

Methods: This cross-sectional observational study will recruit 400 MASLD patients (100 each group) at AIIMS, New Delhi. Body composition will be assessed using BIA scan, liver steatosis and fibrosis will be evaluated through FibroScan. Biochemical markers, muscle strength, and quality of life will also be analysed.

Expected Outcome: The study aims to establish associations between Adipose-Muscle Phenotypes and clinical/metabolic parameters in MASLD. Findings could enhance patient stratification and guide personalized treatment strategies, improving long-term metabolic and hepatic outcomes.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Age 18-60 years, Diagnosed with MASLD, Willing to give informed consent, BMI above 18.5.

排除标准

  • Known case or recently diagnosed diabetes mellitus, Participants who have undergone any recent major surgery in the last three months, Any acute or chronic infectious illness, History of pancreatitis or any other diseases requiring dietary modifications or restrictions, Chronic liver, heart and kidney disease, osteoarthritis and advanced end organ damage, Pregnant and lactating women, Presence of seropositivity for Hepatitis B, C and Human Immunodeficiency Virus, Excessive alcohol use more than 20 g per day for women and more than 30 g per day for men, Intake of any anti obesity drugs like orlistat, liraglutide, etc.
  • currently or in the last three months.

结局指标

主要结局

identification of significant associations between Adipose-Muscle Phenotypes characterized by variations in visceral fat and lean mass and clinical and metabolic parameters in MASLD patients

时间窗: One time study

次要结局

  • identification of a significant association between adipose- phenotypes characterized by variation in visceral fat and lean mass - and muscle strength, eating behaviour, sleep quality, and physical activity(One Time study)

研究者

发起方
ICMR
申办方类型
Government funding agency
责任方
Principal Investigator
主要研究者

Prof NAVAL KISHORE VIKRAM

AIIMS, New Delhi

研究点 (1)

Loading locations...

相似试验